Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Leurs
C. Leurs
VU University Amsterdam
Multiple sclerosis
Natalizumab
Medicine
Physical therapy
Cohort
2
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
2021
Multiple Sclerosis Journal
Zoë Y.G. van Lierop
Luuk Wieske
Marleen Ja Koel-Simmelink
Madhurima Chatterjee
Iris Dekker
C. Leurs
Eline A.J. Willemse
B. Moraal
Frederik Barkhof
Filip Eftimov
Bernhard Mj Uitdehaag
Joep Killestein
Charlotte E. Teunissen
Show All
Source
Cite
Save
Citations (1)
High cumulative JC virus seroconversion rate during long-term use of natalizumab.
2016
European Journal of Neurology
A. Vennegoor
J.H.A. van Rossum
C. Leurs
Mike P. Wattjes
Theo Rispens
J. L. A. N. Murk
Bernard M. J. Uitdehaag
Joep Killestein
Show All
Source
Cite
Save
Citations (38)
1